| Thymus Carcinoma studied in …STUDIED_INderived58 of 58show fewer |
|---|
| → studied in | NCT03076554Phase 2 · active not recruiting A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ALIAS · 58 trials mapped (24 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06980077Phase 2 · recruiting Ivonescimab for the Treatment of Thymic Cancer · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824505Phase 2 · completed Lucitanib (AL3810) in Patients With Advanced Thymic Carcinoma After Chemotherapy · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06248515Phase 2 · recruiting A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07324629Phase 2 · recruiting Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03463460Phase 2 · active not recruiting Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750353Phase 2 · not yet recruiting A Phase II, Investigator-Initiated Exploratory Study of Sacituzumab Tirumotecan for Previously Treated Unresectable Thymic Carcinomas · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01025089Phase 2 · active not recruiting Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295227Phase 1 · recruiting Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07693855NA · not yet recruiting Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07598955Phase 1/Phase 2 · recruiting Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2 Thymoma or Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03134118Phase 2 · active not recruiting Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06019468Phase 2 · recruiting Neoadjuvant Treatment For Locally Advanced Thymic Cancer · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06402708Phase 3 · recruiting Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3) · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06141369NA · recruiting Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) · condition mapped ALIAS · 58 trials mapped (24 active) | — | — | Thymus Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07479628Phase 2 · not yet recruiting Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04710628Phase 2 · completed Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328074not yet recruiting Electrocautery Resection Combined With HITHOC for Thymic Epithelial Tumors With Pleural Metastasis · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544929Phase 1 · active not recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385722enrolling by invitation Molecular Analysis of Thoracic Malignancies · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06838910Phase 2 · recruiting Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03694002Phase 2 · completed Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07179341NA · completed Survival Nomogram for Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05667948recruiting Molecular Analysis and Treatment Options of Thymic Malignancies · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583086Phase 1/Phase 2 · completed Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01306045Phase 2 · completed Molecular Profiling and Targeted Therapy for Advanced Non-Small Cell Lung Cancer, Small Cell Lung Cancer, and Thymic Malignancies · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04321330Phase 2 · completed A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03921671Phase 2 · unknown Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04925947Phase 2 · terminated A Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06301945recruiting Artificial Intelligence Prediction Tool in Thymic Epithelial Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04469725Phase 2 · terminated KN046 (a Humanized PD-L1/CTLA4 Bispecific Single Domain Fc Fusion Protein Antibody) in Subjects With Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04662645NA · completed Embedded Palliative Care in Managing Symptoms in Participants With Recurrent Stage III-IV Thoracic Malignancies and Their Caregivers · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00010257Phase 2 · completed Carboplatin Combined With Paclitaxel in Treating Patients With Advanced Thymoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430842Phase 1 · completed Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517488Phase 1 · completed A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307500Phase 2 · completed Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03449173Phase 2 · unknown Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial) · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614818unknown A Multi-center, Retrospective Analysis of Clinical Character, Outcome and Prognosis of Lymphoepithelioma-like Carcinoma · condition mapped ALIAS · 58 trials mapped (24 active) | — | — | Thymus Lymphoepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01143545Phase 1 · terminated Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02364076Phase 2 · unknown Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02062632Phase 2 · terminated Doxepin Hydrochloride in Treating Esophageal Pain in Patients With Thoracic Cancer Receiving Radiation Therapy to the Thorax With or Without Chemotherapy · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00198133Phase 2 · completed Phase II Study of Alimta (Pemetrexed) Treatment of Advanced Thymoma and Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01364727Phase 2 · completed A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011439Phase 2 · terminated Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02623127Phase 2 · completed A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01100944Phase 1/Phase 2 · terminated A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170804unknown Genomic Profiling of Nodular Thyroid Disease and Thyroid Cancer · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00965250Phase 2 · completed Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589290Phase 2 · completed Belinostat (PXD101) to Treat Tumors of the Thymus at an Advanced Stage · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00314873Phase 1 · completed Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00818090Phase 2 · terminated Paclitaxel and Cisplatin for Thymic Neoplasm · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003662Phase 2 · completed Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases · condition mapped CURATED_BROADER · 58 trials mapped (24 active) | — | — | Thymus Carcinoma | 1 | Observed | clinicaltrials | graph → |